Search

Your search keyword '"TIRODE, Franck"' showing total 679 results

Search Constraints

Start Over You searched for: Author "TIRODE, Franck" Remove constraint Author: "TIRODE, Franck"
679 results on '"TIRODE, Franck"'

Search Results

4. Wnt/β-Catenin–Activated Nonpilomatrical Carcinoma of the Skin: A Case Series

5. Beneath HMGA2 alterations in pleomorphic adenomas: Pathological, immunohistochemical, and molecular insights

7. SOX10-Internal Tandem Duplications and PLAG1 or HMGA2 Fusions Segregate Eccrine-Type and Apocrine-Type Cutaneous Mixed Tumors

8. A Combination of MTAP and p16 Immunohistochemistry Can Substitute for CDKN2A Fluorescence In Situ Hybridization in Diagnosis and Prognosis of Pleural Mesotheliomas

9. Fusion partners of NTRK3 affect subcellular localization of the fusion kinase and cytomorphology of melanocytes

14. Targeted long-read sequencing of the Ewing sarcoma 6p25.1 susceptibility locus identifies germline-somatic interactions with EWSR1-FLI1 binding

16. Sweat Gland Tumors Arising on Acral Sites: A Molecular Survey

18. Exploring the molecular landscape of cutaneous mixed tumors characterized by TRPS1::PLAG1 gene fusion.

19. Solid papillary mesothelial tumor

20. An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma

23. Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model

27. Porocarcinomas with PAK1/2/3 fusions: a series of 12 cases.

28. NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker

30. Comprehensive Molecular and Pathologic Evaluation of Transitional Mesothelioma Assisted by Deep Learning Approach: A Multi-Institutional Study of the International Mesothelioma Panel from the MESOPATH Reference Center

32. A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation

34. Uncovering the WWTR1::NCOA2 Gene fusion in low‐grade myoepithelial‐rich neoplasm with HMGA2 expression: A case report

35. Transcriptional Programs Define Intratumoral Heterogeneity of Ewing Sarcoma at Single-Cell Resolution

38. Comprehensive Molecular Characterization of a Large Series of Calcified Chondroid Mesenchymal Neoplasms Widening Their Morphologic Spectrum.

43. Alternative PDGFD rearrangements in dermatofibrosarcomas protuberans without PDGFB fusions

44. Translational Aspects of Epithelioid Sarcoma: Current Consensus

45. Supplementary Table S4 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers

46. FIGURE 4 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers

47. FIGURE 2 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers

48. Supplementary Figure S3 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers

49. FIGURE 3 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers

50. FIGURE 1 from An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers

Catalog

Books, media, physical & digital resources